Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)

Clinical trial NCT02666664 · COMPLETED

Trial details

NCT number

NCT02666664

Sponsor

Esperion Therapeutics, Inc.

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2016-01-21

Primary completion

2018-02-21

Enrollment

2230

View on ClinicalTrials.gov